Volume 11, Issue 4 (12-2023)                   JoMMID 2023, 11(4): 185-191 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shraddha Dinkarrao N, Harish Subhashrao G, Smita Sitaram K, Manjushree Vijay M. Detecting Carbapenem Resistance in Enterobacteriaceae Isolates Using Carbapenem Discs and the Modified Hodge Test at a Tertiary Care Hospital in Maharashtra, India. JoMMID 2023; 11 (4) :185-191
URL: http://jommid.pasteur.ac.ir/article-1-547-en.html
Department of Microbiology, Mahatma Gandhi Mission’s Medical College and Hospital, Aurangabad, Maharashtra, India
Abstract:   (668 Views)
Introduction: The emergence of carbapenem-resistant Enterobacteriaceae (CRE) poses a significant public health concern due to its potential for increased mortality and morbidity. The limited availability of effective antibiotics further exacerbates the dissemination of carbapenem-resistant bacteria. This study aimed to evaluate the prevalence of carbapenem resistance and carbapenemase production in Enterobacteriaceae isolates using the Modified Hodge Test. Methods: This observational study was conducted at the Department of Microbiology, MGM Medical College & Hospital, Aurangabad, Maharashtra, from November 2015 to November 2017. 171 Enterobacteriaceae isolates from various clinical samples were comprehensively tested for carbapenem resistance and carbapenemase production. This involved the use of carbapenem discs (ertapenem, meropenem, and imipenem), E-test strips for ertapenem and meropenem, and the Modified Hodge Test (MHT) for carbapenemase identification. Results: Among the 171 tested Enterobacteriaceae isolates, a substantial proportion (40%) displayed resistance to carbapenems, as determined by disc diffusion and E-test methods. Among the carbapenem-resistant isolates, 13 were positive for the MHT. Conclusion: Our study revealed a notable prevalence of carbapenem resistance in Enterobacteriaceae isolates from a tertiary care hospital. The MHT, following Clinical and Laboratory Standards Institute (CLSI) guidelines, demonstrated high sensitivity (> 90%) and specificity (> 90%) for detecting KPC-type carbapenemases in these isolates. Treatment options for CRE infections are limited, with tigecycline and colistin identified as potential options. Our study highlights the importance of promptly diagnosing different carbapenemases using PCR techniques. Consequently, we strongly advocate for implementing robust antimicrobial stewardship programs and infection control practices in healthcare settings to prevent CRE spread effectively.
Full-Text [PDF 602 kb]   (173 Downloads)    
Type of Study: Original article | Subject: Anti-microbial agents, resistance and treatment protocols
Received: 2023/05/19 | Accepted: 2023/12/10 | Published: 2024/02/24

References
1. Eisenstein BI, Zaleznik DF. Enterobacteriaceae. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases, 5thed. Philadelphia, Pa: Churchill Livingstone; 2000 p. 2294-310.
2. Livermore DM. β-lactamase mediated resistance and opportunities for its control. J Antimicrob Chemother. 1998; 41 (Suppl D): 25-41. [DOI:10.1093/jac/41.suppl_4.25] [PMID]
3. Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum beta lactamase producing Gram negative bacteria in a tertiary care hospital. Indian J Med Res. 2002; 115: 153-7.
4. Mohanty S, Kapil A, Das BK, Dhawan B. Antimicrobial resistance profile of nosocomial uropathogens in a tertiary care hospital. Indian J Med Sci. 2003; 57 (4): 148-54.
5. Jain A, Roy I, Gupta MK, Kumar M, Agarwal SK. Prevalence of extended-spectrum β-lactamase producing Gram-negative bacteria in septicaemic neonates in a tertiary care hospital. J Med Microbiol. 2003; 52 (Pt 5): 421-5 [DOI:10.1099/jmm.0.04966-0] [PMID]
6. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention. Clin Infect Dis. 2011; 53 (1): 60-7. [DOI:10.1093/cid/cir202] [PMID]
7. Nair PK, Vaz MS. Prevalence of carbapenem resistant Enterobacteriaceae from a tertiary care hospital in Mumbai. JMID. 2013; 3 (4): 207-10. [DOI:10.5799/ahinjs.02.2013.04.0110]
8. CDC. Facility Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE): CRE Toolkit. November 2015 Update.
9. Walsh TR. Emerging carbapenemases: A global perspective. Int J Antimicrob Agents. 2010; 36 Suppl 3: S8-14. [DOI:10.1016/S0924-8579(10)70004-2] [PMID]
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Fifth Informational Supplement (M100-S25. CLSI). Wayne, PA: USA; 2015.
11. Collee JG, Fraser AG, Marmion BP, Simmons A. Mackie and McCartney Practical Medical Microbiology.14th ed. Churchill Livingstone, India; 1996.
12. Bauer AW, Kirby WMM, Sherris JC, Tuck M. Antibiotics susceptibility testing by standard single disc method. Am J Clin Pathol. 1996; 45 (4): 493-6. [DOI:10.1093/ajcp/45.4_ts.493] [PMID]
13. Mate H, Devi S, Devi M, Damrolien S, Devi LN, Devi PP. Prevalance of Carbapenem resistance among Gram-Negative Bacteria in a Tertiary Care Hospital in North-East India. IOSR-JDMS. 2014; 13 (12): 56-60. [DOI:10.9790/0853-131235660]
14. Mulla S, Charan J, Panvala T. Antibiotic sensitivity of Enterobacteriaceae at a tertiary care center in India. Chron Young Sci. 2011; 2 (4): 214-18. [DOI:10.4103/2229-5186.93028]
15. Mariappan S, Sekar U, Kamalanathan A. Carbapenemase-producing Enterobacteriaceae: Risk factors for infection and impact of resistance on outcomes. Int J App Basic Med Res. 2017; 7 (1): 32-9. [DOI:10.4103/2229-516X.198520] [PMID] []
16. Datta P, Gupta V, Garg S, Chander J. Phenotypic method for differentiation of carbapenemases in Enterobacteriaceae: Study from north India. Indian J Pathol Microbiol. 2012; 55 (3): 357-60. [DOI:10.4103/0377-4929.101744] [PMID]
17. Gupta E, Mohanty S, Sood S, DhawanB, Das BK, Kapil A. Emerging resistance to carbapenems in a tertiary care hospital in north India. Indian J Med Res. 2006; 124 (1): 95-8.
18. Chauhan K, Pandey A, Asthana AK, Madan M. Evaluation of phenotypic tests for detection of Klebsiella pneumonia carbapenemase and metallo-beta-lactamase in clinical isolates of Escherichia coli and Klebsiella species. Indian J Pathol Microbiol. 2015; 58 (1): 31-5. [DOI:10.4103/0377-4929.151168] [PMID]
19. Wattal C, Goel N, Oberoi JK, Raveendran R, Datta S, Prassad KJ. Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India. J Assoc Physicians India. 2010; 58: 32-6.
20. Nagaraj S, Chandran SP, Shamanna P, Macaden R. Carbapenem resistance among Escherichia coli and Klebsiella pneumoniae in a tertiary care hospital in South India. Indian J Med Microbiol. 2012; 30 (1): 93-5. [DOI:10.4103/0255-0857.93054] [PMID]
21. Sekar R, Srivani S, Amudhan M, Mythreyee M. Carbapenem resistance in a rural part of southern India: Escherichia coli versus Klebsiella spp. Indian J Med Res. 2016; 144 (5): 781-3. [DOI:10.4103/ijmr.IJMR_1035_15] [PMID] []
22. Mahajan G, Sheemar S, Chopra S, Kaur J, Chowdhary D, Makhija SK. Carbapenem resistance and phenotypic detection of carbapenemases in clinical isolates of Acinetobacter baumannii. Indian J Med Sci. 2011; 65 (1): 18-25. [DOI:10.4103/0019-5359.103161] [PMID]
23. Sathya P, Shamsadh B, Anbumani N. Phenotypic Detection Methods of Carbapenemase Production in Enterobacteriaceae. Int J Curr Microbiol App Sci. 2015; 4 (6): 547-52.
24. Jeremiah SS, Balaji V, Anandan S, Sahni RD. A possible alternative to the error prone modified Hodge test to correctly identify the carbapenemase producing Gram-negative bacteria. Indian J Med Microbiol. 2014; 32 (4): 414-8. [DOI:10.4103/0255-0857.142258] [PMID]
25. Baran I, Aksu N. Phenotypic and genotypic characteristics of carbapenem resistant Enterobacteriaceae in a tertiary level reference hospital in Turkey. Ann Clin Microbiol Antimicrob. 2016; 15 (1): 20. [DOI:10.1186/s12941-016-0136-2] [PMID] []
26. Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2001; 7 (2): 88-91. [DOI:10.1046/j.1469-0691.2001.00204.x] [PMID]
27. Ramana KV, Rao R, Sharada C, Kareem MA, Reddy LR, Ratna Mani MS. Modified Hodge test: A useful and the lowcost phenotypic method for detection of carbapenemase producers in Enterobacteriaceae members. J Nat Sc Biol Med. 2013; 4 (2): 346-8. [DOI:10.4103/0976-9668.117009] [PMID] []
28. Bratu S, Tolaney P, Karumudi U, Quale J, Mooty M, Nichani S, et al. Carbapenemase-producing Klebsiella peneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of plymyxin B and other agents. J Antimicrob Chemother. 2005; 56 (1): 128-32. [DOI:10.1093/jac/dki175] [PMID]
29. Manoharan A, Barla GS, Peter R, Sugumar M, Mathai D. Multidrug resistance mediated by co-carriage of extendedspectrum beta-lactamases, AmpC and New Delhi metallo betalactamase-1 genes among carbapenem-resistant Enterobacteriaceae at five Indian medical centres. Indian J Med Microbiol. 2016; 34 (3): 359-61. [DOI:10.4103/0255-0857.188350] [PMID]
30. Chakkarapani AA, Amboiram P, Balakrishnan U, Ninan B, Sekar U. Pattern and antimicrobial susceptibility of carbapenem resistant organisms in tertiary care neonatal intensive care unit, India. J Clin Neonatol. 2014; 3 (4): 200-4. [DOI:10.4103/2249-4847.144750]
31. Federico Perez, David Van Duin. Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients. Cleve Clin J Med. 2013; 80 (4): 225-33. [DOI:10.3949/ccjm.80a.12182] [PMID] []

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.